SteriLance Medical received the 2022 Suzhou Quality Award, recognizing its leadership in product quality, innovation, and customer satisfaction in the capillary blood collection industry.
SteriLance Medical was recognized in Suzhou’s Intellectual Property Peak Action Project for its leadership in high-value patents and innovation. With 154 patents and 124 trademarks, SteriLance advances its IP strategy to enhance competitiveness.
The "Disposable Safety Heel Incision Lancet," developed and produced by SteriLance Medical, has been honored with the China Patent Excellence Award at the 22nd China Patent Awards, hosted by the China National Intellectual Property Administration.